4 NASH Clinical Trials in Birmingham, AL (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting NASH Studies in Birmingham

NCT06632444Recruiting

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

This study is open to adults who are at least 18 years old living with obesity and have: * a confirmed liver disease called non-alcoholic steatohepatitis (NASH)/metabolic associated steatohepatitis (...

Birmingham, ALPHASE31,800 participantsBoehringer Ingelheim

View Study Details

NCT06215716Recruiting

A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The stud...

Birmingham, ALPHASE31,650 participantsAkero Therapeutics, Inc

View Study Details

NCT06318169Recruiting

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

The study will assess the efficacy and safety of 2 dose regimens of pegozafermin for the treatment of liver fibrosis stage 2 or 3 in adult participants with MASH (previously known as nonalcoholic stea...

Birmingham, ALPHASE31,350 participants89bio, Inc.

View Study Details

NCT06419374Recruiting

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

The study will assess the efficacy and safety of pegozafermin administered in participants with compensated cirrhosis due to MASH (biopsy-confirmed fibrosis stage F4 MASH \[previously known as nonalco...

Birmingham, ALPHASE3762 participants89bio, Inc.

View Study Details

About NASH Clinical Trials in Birmingham

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 4 nash clinical trials recruiting participants in Birmingham, AL. These studies are seeking a combined 5,562 participants. Research is being sponsored by Boehringer Ingelheim, Akero Therapeutics, Inc, 89bio, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in Birmingham — FAQ

Are there nash clinical trials in Birmingham?

Yes, there are 4 nash clinical trials currently recruiting in Birmingham, AL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What nash treatments are being tested?

The 4 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated September 1, 2026 from ClinicalTrials.gov